BD
BioAdaptives Inc.
BDPT · OTC
$0.00 -5.00% (-$0.00)
1M +63.89%
Market Cap $21.6K
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
$0
100.0% downside
Current Price
$0.0019
Undervalued Fair Value Overvalued
According to Bulios Fair Price, BDPT is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/S 0.85x
P/E N/A
P/FFO N/A
Growth
30 /100
Declining Rev. growth 2.09%
EPS growth N/A
Book val. growth N/A
Profitability
20 /100
Weak Gross margin 74.48%
FCF margin 1,097.43%
Net margin 4,553.73%
Quality
63 /100
Average ROIC 73.00%
Asset turnover 0.32x
ROA 1,477.75%
Debt
0 /100
High Current ratio 0.04x
Int. coverage -48.33x
Debt/Equity N/A
Stability
23 /100
Unstable Beta 1.19x
Profitable years 0
Rev. volatility 64.99%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about BDPT
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
James Keener
Employees
1
Headquarters
Las Vegas